Haleon (HLNCF) Income from Continuing Operations (2021 - 2023)
Haleon (HLNCF) recorded quarterly Income from Continuing Operations of 767031865.17 in Q4 2023, up 17.65% on a QoQ basis from 651960202.73 in Q2 2023, and up 4.63% year-over-year from 733080200.71 in Q4 2022.
Haleon (HLNCF) Income from Continuing Operations (2021 - 2023) Analysis & Trends
Haleon has disclosed Income from Continuing Operations across 3 years of filings, most recently posting 767031865.17 for Q4 2023.
- Quarterly Income from Continuing Operations rose 4.63% year-over-year to 767031865.17 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 2970110629.68 (changed N/A YoY) and the FY2025 annual result came in at 2215097364.33, up 17.48% from the prior year.
- Income from Continuing Operations climbed to 767031865.17 in Q4 2023, from 651960202.73 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 1457853310.52 in Q3 2022 and troughed at 651960202.73 in Q2 2023.
- A 3-year average of 879984440.66 and a median of 792535113.12 in 2023 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations slipped 13.95% — and 2023, when it increased 4.63%.
- Tracing HLNCF's Income from Continuing Operations over 3 years: stood at 851942703.74 in 2021, then decreased by 13.95% to 733080200.71 in 2022, then advanced by 4.63% to 767031865.17 in 2023.
- Business Quant data shows HLNCF's Income from Continuing Operations at 767031865.17 in Q4 2023, 651960202.73 in Q2 2023, and 818038361.07 in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 370.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 21.05 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -92.12 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 118.42 Mn |
| 10 | Haleon | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 767.03 Mn |
| Jun 30, 2023 | 651.96 Mn |
| May 3, 2023 | 818.04 Mn |
| Dec 31, 2022 | 733.08 Mn |
| Sep 20, 2022 | 1.46 Bn |
| Dec 31, 2021 | 851.94 Mn |